Mankind Pharma consolidated net profit rises 39.09% in the September 2026 quarter

Sales rise 17.33% to Rs 4337.86 crore

Net profit of Mankind Pharma rose 39.09% to Rs 711.48 crore in the quarter ended September 2026 as against Rs 511.51 crore during the previous quarter ended September 2025. Sales rose 17.33% to Rs 4337.86 crore in the quarter ended September 2026 as against Rs 3697.16 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	4337.86	3697.16	17
OPM %	27.00	24.92	-
PBDT	1164.84	845.84	38
PBT	929.11	624.02	49
NP	711.48	511.51	39

Powered by Capital Market - Live News